Vaccine containing immunologic adjuvants with a wide range of activity to provide protection against COVID-19
dc.contributor.author | Berhanu, Mulugeta | |
dc.date.accessioned | 2024-03-17T17:54:34Z | |
dc.date.available | 2024-03-17T17:54:34Z | |
dc.date.issued | 2021-07-30 | |
dc.description.abstract | COVID-19 is a devastating viral disease which can be prevented by vaccination. Immunologic adjuvants are key to develop an effective vaccines against infectious diseases in human and non-human primates. Vaccines containing an appropriate adjuvants are crucial for the prevention of various infectious diseases which are the biggest threats to human and animal health. This paper proposes a wide spectrum immunologic adjuvant for vaccine development against COVID-19 which is the current global problem. It has been reported that a wide range of immune cells are involved in the body’s response to SARS CoV2 infection. Therefore, vaccine with a wide-spectrum immunologic adjuvant can be used to provide protection against COVID-19. Lack of adjuvants that can induce the required immune responses is a serious impediment to vaccine development against this devastating virus. The approved adjuvants such as aluminum salts and MF59 exhibit a narrow range of activity. In an attempt to solve this problem, it is crucial to develop new adjuvants which can trigger a wide range of immune cells. | |
dc.identifier.doi | https://doi.org/10.31730/osf.io/es9cf | |
dc.identifier.uri | https://africarxiv.ubuntunet.net/handle/1/731 | |
dc.identifier.uri | https://doi.org/10.60763/africarxiv/687 | |
dc.identifier.uri | https://doi.org/10.60763/africarxiv/687 | |
dc.identifier.uri | https://doi.org/10.60763/africarxiv/687 | |
dc.subject | Adjuvants for COVID-19vaccines | |
dc.subject | Aluminumsalts | |
dc.subject | COVID-19 | |
dc.subject | Immunologic adjuvants | |
dc.subject | MF-59 | |
dc.subject | SARS CoV2 | |
dc.subject | Vaccine development against COVID-19 | |
dc.subject | Vaccine with a wide-spectrum immunologic adjuvant | |
dc.title | Vaccine containing immunologic adjuvants with a wide range of activity to provide protection against COVID-19 |